{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T01:57:40Z","timestamp":1784858260151,"version":"3.55.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T00:00:00Z","timestamp":1672790400000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003130","name":"FWO","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013322","name":"European Federation of Pharmaceutical Industries and Associations","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020098","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["115952"],"award-info":[{"award-number":["115952"]}],"id":[{"id":"10.13039\/100020098","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroImage: Clinical"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/j.nicl.2023.103321","type":"journal-article","created":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T12:39:35Z","timestamp":1672922375000},"page":"103321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Longitudinal changes in 18F-Flutemetamol amyloid load in cognitively intact APOE4 carriers versus noncarriers: Methodological considerations"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1777-4742","authenticated-orcid":false,"given":"Emma S.","family":"Luckett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolien","family":"Schaeverbeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffi","family":"De Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Adamczuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Van Laere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Dupont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rik","family":"Vandenberghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nicl.2023.103321_b0005","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.nicl.2013.04.001","article-title":"Polymorphism of brain derived neurotrophic factor influences \u03b2 amyloid load in cognitively intact apolipoprotein \u03b54 carriers","volume":"2","author":"Adamczuk","year":"2013","journal-title":"Neuroimage Clin."},{"key":"10.1016\/j.nicl.2023.103321_b0010","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s00259-015-3156-9","article-title":"Amyloid imaging in cognitively normal older adults: comparison between 18F-flutemetamol and 11C-Pittsburgh compound B","volume":"43","author":"Adamczuk","year":"2016","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"8","key":"10.1016\/j.nicl.2023.103321_b0015","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1007\/s00259-017-3666-8","article-title":"Reference region selection and the association between the rate of amyloid accumulation over time and the baseline amyloid burden","volume":"44","author":"Blautzik","year":"2017","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.nicl.2023.103321_b0020","doi-asserted-by":"crossref","first-page":"7709","DOI":"10.1523\/JNEUROSCI.2177-05.2005","article-title":"Molecular, structural, and functional characterization of Alzheimer\u2019s disease: Evidence for a relationship between default activity, amyloid, and memory","volume":"25","author":"Buckner","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nicl.2023.103321_b0025","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.2967\/jnumed.116.187351","article-title":"Optimal reference region to measure longitudinal amyloid-b change with 18F-Florbetaben PET","volume":"58","author":"Bullich","year":"2017","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.nicl.2023.103321_b0030","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neurobiolaging.2020.06.001","article-title":"Impact of APOE-\u03b54 carriage on the onset and rates of neocortical A\u03b2-amyloid deposition","volume":"95","author":"Burnham","year":"2020","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nicl.2023.103321_b0035","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s00259-019-04533-y","article-title":"[18F]Florbetapir PET\/MR imaging to assess demyelination in multiple sclerosis","volume":"47","author":"Carotenuto","year":"2020","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.nicl.2023.103321_b0040","doi-asserted-by":"crossref","first-page":"560","DOI":"10.2967\/jnumed.114.149732","article-title":"Improved power for characterizing longitudinal amyloid-\u03b2PET changes and evaluating amyloid-modifying treatments with a cerebral white matter reference region","volume":"56","author":"Chen","year":"2015","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.nicl.2023.103321_b0045","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2967\/jnumed.118.209130","article-title":"Impact of reference and target region selection on amyloid PET SUV ratios in the phase 1B PRIME study of aducanumab","volume":"60","author":"Chiao","year":"2019","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.nicl.2023.103321_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-76102-5","article-title":"Concordance in detecting amyloid positivity between 18F-florbetaben and 18F-flutemetamol amyloid PET using quantitative and qualitative assessments","volume":"10","author":"Cho","year":"2020","journal-title":"Sci. Rep."},{"issue":"261","key":"10.1016\/j.nicl.2023.103321_b0060","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families","volume":"1979","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.nicl.2023.103321_b0065","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13195-020-00728-w","article-title":"Comparison of ELISA- and SIMOA-based quantification of plasma A\u03b2 ratios for early detection of cerebral amyloidosis","volume":"12","author":"de Meyer","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.nicl.2023.103321_b0070","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1212\/WNL.0b013e3181a2e8d0","article-title":"Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease","volume":"72","author":"Drzezga","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.nicl.2023.103321_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2012.04.017","article-title":"Apolipoprotein E \u03b54 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease","volume":"34","author":"Fleisher","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nicl.2023.103321_b0080","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.biopsych.2010.05.013","article-title":"Progression of cerebral amyloid load is associated with the apolipoprotein e \u03b54 genotype in Alzheimer\u2019s disease","volume":"68","author":"Grimmer","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.nicl.2023.103321_b0085","doi-asserted-by":"crossref","DOI":"10.1186\/s13550-020-00714-1","article-title":"[11C]PIB amyloid quantification: effect of reference region selection","volume":"10","author":"Heeman","year":"2020","journal-title":"EJNMMI Res."},{"key":"10.1016\/j.nicl.2023.103321_b0090","doi-asserted-by":"crossref","first-page":"14307","DOI":"10.1038\/s41598-022-18325-2","article-title":"Correlations between APOE4 allele and regional amyloid and tau burdens in cognitively normal older individuals","volume":"12","author":"Hong","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nicl.2023.103321_b0095","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcaa007","article-title":"Neuroanatomical spread of amyloid \u03b2 and tau in Alzheimer\u2019s disease: implications for primary prevention","volume":"2","author":"Insel","year":"2020","journal-title":"Brain Commun."},{"issue":"4","key":"10.1016\/j.nicl.2023.103321_b0100","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimer\u2019s Dementia"},{"key":"10.1016\/j.nicl.2023.103321_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2014.07.003","article-title":"The Centiloid project: Standardizing quantitative amyloid plaque estimation by PET","volume":"11","author":"Klunk","year":"2015","journal-title":"Alzheimer\u2019s Dementia"},{"key":"10.1016\/j.nicl.2023.103321_b0110","doi-asserted-by":"crossref","first-page":"818","DOI":"10.2967\/jnumed.108.060756","article-title":"Whole-body biodistribution and radiation dosimetry of 18F-GE067: A radioligand for in vivo brain amyloid imaging","volume":"50","author":"Koole","year":"2009","journal-title":"J. Nucl. Med."},{"issue":"2","key":"10.1016\/j.nicl.2023.103321_b0115","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jalz.2018.09.001","article-title":"Multisite study of the relationships between antemortem [11 C]PIB-PET Centiloid values and postmortem measures of Alzheimer\u2019s disease neuropathology","volume":"15","author":"La Joie","year":"2019","journal-title":"Alzheimer\u2019s Dementia"},{"issue":"7","key":"10.1016\/j.nicl.2023.103321_b0120","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1007\/s00259-014-2753-3","article-title":"Amyloid PET imaging in Alzheimer\u2019s disease: A comparison of three radiotracers","volume":"41","author":"Landau","year":"2014","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.nicl.2023.103321_b0125","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2967\/jnumed.114.148981","article-title":"Measurement of longitudinal \u03b2-amyloid change with 18F-florbetapir PET and standardized uptake value ratios","volume":"56","author":"Landau","year":"2015","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.nicl.2023.103321_b0130","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/jnnp-2013-305858","article-title":"Greater medial temporal hypometabolism and lower cortical amyloid burden in ApoE4-positive AD patients","volume":"85","author":"Lehmann","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"10","key":"10.1016\/j.nicl.2023.103321_b0135","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1212\/WNL.0000000000004336","article-title":"APOE genotype and early \u03b2-amyloid accumulation in older adults without dementia","volume":"89","author":"Lim","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.nicl.2023.103321_b0140","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.nicl.2017.08.011","article-title":"Comparison of [18F]Flutemetamol and [11C]Pittsburgh Compound-B in cognitively normal young, cognitively normal elderly, and Alzheimer\u2019s disease dementia individuals","volume":"16","author":"Lowe","year":"2017","journal-title":"Neuroimage Clin."},{"issue":"10","key":"10.1016\/j.nicl.2023.103321_b0145","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.2967\/jnumed.117.204271","article-title":"White matter reference region in PET studies of 11C-Pittsburgh compound B uptake: Effects of age and amyloid-\u03b2 deposition","volume":"59","author":"Lowe","year":"2018","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.nicl.2023.103321_b0150","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jamaneurol.2019.2214","article-title":"Staging \u03b2 -Amyloid Pathology with Amyloid Positron Emission Tomography","volume":"76","author":"Mattsson","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.nicl.2023.103321_b0155","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.nicl.2018.04.007","article-title":"Impact of partial volume correction on the regional correspondence between in vivo [C-11]PiB PET and postmortem measures of A\u03b2 load","volume":"19","author":"Minhas","year":"2018","journal-title":"Neuroimage Clin."},{"key":"10.1016\/j.nicl.2023.103321_b0160","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1093\/brain\/awy103","article-title":"Longitudinal brain imaging in preclinical Alzheimer disease: Impact of APOE \u220a4 genotype","volume":"141","author":"Mishra","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.nicl.2023.103321_b0165","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ana.21843","article-title":"APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging","volume":"67","author":"Morris","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nicl.2023.103321_b0170","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.nicl.2015.10.007","article-title":"Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer\u2019s subjects","volume":"9","author":"Mountz","year":"2015","journal-title":"Neuroimage Clin."},{"issue":"12","key":"10.1016\/j.nicl.2023.103321_b0175","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1097\/NEN.0b013e318277387e","article-title":"A quantitative postmortem MRI design sensitive to white matter hyperintensity differences and their relationship with underlying pathology","volume":"71","author":"Murray","year":"2012","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nicl.2023.103321_b0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-01150-x","article-title":"Earliest accumulation of \u03b2-amyloid occurs within the default-mode network and concurrently affects brain connectivity","volume":"8","author":"Palmqvist","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nicl.2023.103321_b0185","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.1073\/pnas.0900345106","article-title":"Fibrillar amyloid-\u03b2 burden in cognitively normal people at 3 levels of genetic risk for Alzheimer\u2019s disease","volume":"106","author":"Reiman","year":"2009","journal-title":"PNAS"},{"issue":"11","key":"10.1016\/j.nicl.2023.103321_b0190","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1007\/s00259-022-05808-7","article-title":"Classification of 18F-Flutemetamol scans in cognitively normal older adults using machine learning trained with neuropathology as ground truth","volume":"49","author":"Reinartz","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.nicl.2023.103321_b0195","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.neurobiolaging.2010.04.007","article-title":"Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging","volume":"31","author":"Rowe","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nicl.2023.103321_b0200","first-page":"25","article-title":"Performance of [18F]flutemetamol amyloid imaging against the neuritic plaque component of CERAD and the current (2012) NIA-AA recommendations for the neuropathologic diagnosis of Alzheimer\u2019s disease","volume":"9","author":"Salloway","year":"2017","journal-title":"Alzheimer\u2019s Dementia"},{"key":"10.1016\/j.nicl.2023.103321_b0205","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-021-00798-4","article-title":"Baseline cognition is the best predictor of 4-year cognitive change in cognitively intact older adults","volume":"13","author":"Schaeverbeke","year":"2021","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.nicl.2023.103321_b0210","first-page":"e12227","article-title":"Lack of association between bridging integrator 1 (BIN1) rs744373 polymorphism and tau-PET load in cognitively intact older adults","volume":"8","author":"Schaeverbeke","year":"2022","journal-title":"Alzheimer\u2019s Dementia: Transl. Res. Clin. Intervent."},{"key":"10.1016\/j.nicl.2023.103321_b0215","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3233\/JAD-180749","article-title":"A Comparison of Partial Volume Correction Techniques for Measuring Change in Serial Amyloid PET SUVR","volume":"67","author":"Schwarz","year":"2019","journal-title":"J. Alzheimer\u2019s Dis."},{"issue":"3","key":"10.1016\/j.nicl.2023.103321_b0220","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3233\/JAD-181282","article-title":"APOE Effect on Amyloid-\u03b2 PET Spatial Distribution, Deposition Rate, and Cut-Points","volume":"69","author":"Toledo","year":"2019","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.nicl.2023.103321_b0225","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/nimg.2001.0978","article-title":"Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain","volume":"15","author":"Tzourio-Mazoyer","year":"2002","journal-title":"Neuroimage"},{"key":"10.1016\/j.nicl.2023.103321_b0230","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ana.22068","article-title":"18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment a phase 2 trial","volume":"68","author":"Vandenberghe","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nicl.2023.103321_b0235","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1093\/brain\/aws125","article-title":"Regional dynamics of amyloid-\u03b2 deposition in healthy elderly, mild cognitive impairment and Alzheimer\u2019s disease: A voxelwise PiB-PET longitudinal study","volume":"135","author":"Villain","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.nicl.2023.103321_b0240","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ana.22248","article-title":"Longitudinal assessment of A\u03b2 and cognition in aging and Alzheimer disease","volume":"69","author":"Villemagne","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nicl.2023.103321_b0245","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","article-title":"Amyloid \u03b2 deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer\u2019s disease: A prospective cohort study","volume":"12","author":"Villemagne","year":"2013","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.nicl.2023.103321_b0250","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.bbadis.2011.11.005","article-title":"PET amyloid-beta imaging in preclinical Alzheimer\u2019s disease","volume":"1822","author":"Vlassenko","year":"2012","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.nicl.2023.103321_b0255","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2967\/jnumed.109.069088","article-title":"In Vivo Imaging of Amyloid Deposition in Alzheimer\u2019s Disease using the Novel Radioligand [18F]AV-45 (Florbetapir F 18)","volume":"51","author":"Wong","year":"2010","journal-title":"J. Nucl. Med."},{"issue":"9","key":"10.1016\/j.nicl.2023.103321_b0260","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","article-title":"Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies","volume":"15","author":"Yamazaki","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.nicl.2023.103321_b0265","first-page":"5","article-title":"A systematic review and meta-analysis of 18F-labeled amyloid imaging in Alzheimer\u2019s disease","volume":"1","author":"Yeo","year":"2015","journal-title":"Alzheimer\u2019s Dementia: Diagn., Assess. Dis. Monit."}],"container-title":["NeuroImage: Clinical"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213158223000104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213158223000104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:34:58Z","timestamp":1781105698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213158223000104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":52,"alternative-id":["S2213158223000104"],"URL":"https:\/\/doi.org\/10.1016\/j.nicl.2023.103321","relation":{},"ISSN":["2213-1582"],"issn-type":[{"value":"2213-1582","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longitudinal changes in 18F-Flutemetamol amyloid load in cognitively intact APOE4 carriers versus noncarriers: Methodological considerations","name":"articletitle","label":"Article Title"},{"value":"NeuroImage: Clinical","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nicl.2023.103321","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103321"}}